| Name | Title | Contact Details |
|---|
Procyrion is developing the first catheter-deployed circulatory assist device intended for long-term use. The Procyrion device will be the first minimally invasive tool for cardiologists to treat over 1M NYHA Class III and early class IV heart failure (HF) patients in the US who have few therapeutic options. In partnership with Texas Heart Institute, Procyrion is currently conducting preclinical testing of the Procyrion device.
RMC Research Corp. is a Arlington, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Surgically Clean Air Inc. is a Etobicoke, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Boston Men's Center is a Costa Mesa, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
VisCardia Inc is a privately held medical device company in Portland Oregon developing a novel chronic heart failure therapy. Our proprietary implantable system uses the patient’s own thoracic musculature to improve cardiac filling and output.